register

News & Trends - Pharmaceuticals

How does Australia’s healthcare system stack up?

Health Industry Hub | September 26, 2024 |

A comparative analysis of health system performance across ten countries, including Australia, reveals critical insights to shape future policy decisions. This evaluation underscores the profound influence of national policy choices on a country’s overall health and wellbeing.

The report focused on five key domains of health system performance: access to care, care processes, administrative efficiency, equity, and health outcomes.

The findings are compelling: Australia’s healthcare system emerged as the “overall” top performer, with the Netherlands and the United Kingdom following closely behind. Interestingly, the two highest-ranked countries, Australia and the Netherlands, also maintain the lowest healthcare spending as a share of GDP.

In stark contrast, the United States ranked last despite spending the highest percentage of GDP (16.5%) on healthcare.

Book your tickets by 1st October – FINALISTS revealed! WINNERS to be crowned at the Awards ceremony on 16th October.

Access to care examined the affordability and availability of services at the population level. The Netherlands, the United Kingdom, and Germany stood out, with both the Netherlands and Germany achieving top scores in affordability and availability.

However, Australia faired poorly when it came to access to care. Roughly half of Australian patients who do not choose to purchase voluntary health insurance have to wait longer to receive services. Affordability is also a noted challenge.

Equity, which measures disparities in healthcare access and experiences between individuals of varying income levels, also presented a mixed picture. Australia and Germany ranked highest, indicating minimal differences in healthcare access and care experiences among residents with below-average and above-average incomes. Conversely, New Zealand and the U.S. landed at the bottom, exhibiting the greatest income-related disparities in access issues and reports of discrimination based on race or ethnicity.

Yet, when the definition of equity expanded to include geographic and gender factors, Australia’s ranking fell dramatically from first to sixth place, reflecting poor performance in rural and remote areas compared to urban counterparts.

Health outcomes, the ultimate measure of a healthcare system’s effectiveness, were assessed through metrics such as life expectancy at birth, excess deaths related to the pandemic, and avoidable deaths. Among the ten countries analysed, Australia, Switzerland, and New Zealand performed the best, while the United States ranked last.

“Despite spending a lot on healthcare, the United States is not meeting one of the principal obligations of a nation: to protect the health and welfare of its residents. Most of the countries we compared are providing this protection, even though each can learn a good deal from its peers. The U.S., in failing this ultimate test of a successful nation, remains an outlier,” the report concluded.

In reimagining healthcare, Health Industry HubTM is the ONLY one-stop-hub uniting the diversity of Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change. The exclusive leadership and influencer podcasts and vodcasts offer unparalleled insights and add immense value to our breaking news coverage.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Pharmaceuticals

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Health Industry Hub | October 11, 2024 |

Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]

More


News & Trends - Pharmaceuticals

New CVD model marks a critical step in the right direction

New CVD model marks a critical step in the right direction

Health Industry Hub | October 11, 2024 |

Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]

More


News & Trends - Pharmaceuticals

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Health Industry Hub | October 11, 2024 |

Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]

More


Leadership & Management

J&J MedTech appoints new ANZ leader

J&J MedTech appoints new ANZ leader

Health Industry Hub | October 10, 2024 |

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]

More


This content is copyright protected. Please subscribe to gain access.